Time after eradication | ||||||
1–3 years | 3–5 years | 5–7.5 years | ||||
No of cases | SIR (95% CI) | No of cases | SIR (95% CI) | No of cases | SIR (95% CI) | |
Total | 48 | 8.65 (6.37 to 11.46) | 21 | 2.02 (1.25 to 3.09) | 6 | 0.31 (0.11 to 0.67) |
Sex | ||||||
Men | 24 | 6.86 (4.39 to 10.20) | 13 | 2.02 (1.08 to 3.46) | 4 | 0.34 (0.09 to 0.87) |
Women | 24 | 11.69 (7.49 to 17.40) | 8 | 2.03 (0.87 to 4.00) | 2 | 0.26 (0.03 to 0.93) |
Age, years | ||||||
18–59 | 14 | 25.71 (14.04 to 43.14) | 4 | 3.57 (0.96 to 9.15) | 0 | NA |
60–69 | 8 | 5.95 (2.56 to 11.71) | 4 | 1.52 (0.41 to 3.88) | 1 | 0.18 (0.00 to 1.02) |
≥70 | 26 | 7.10 (4.64 to 10.40) | 13 | 1.96 (1.05 to 3.36) | 5 | 0.43 (0.14 to 1.00) |
NA, not applicable; SIR, standardised incidence ratio.